pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4745 |
Genomic Coordinates | chr19: 804940 - 805001 |
Description | Homo sapiens miR-4745 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4745-5p | |||||||||||||||||||||||||||||||||||||||||||||
Sequence | 2| UGAGUGGGGCUCCCGGGACGGCG |24 | |||||||||||||||||||||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||||||||||||||||||||
Experiments | Illumina | DRVs in miRNA |
|
|||||||||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | SPCS3 | ||||||||||||||||||||
Synonyms | PRO3567, SPC22/23, SPC3, YLR066W | ||||||||||||||||||||
Description | signal peptidase complex subunit 3 | ||||||||||||||||||||
Transcript | NM_021928 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on SPCS3 | |||||||||||||||||||||
3'UTR of SPCS3 (miRNA target sites are highlighted) |
>SPCS3|NM_021928|3'UTR 1 ATTATTCTGAATTTGAAACAACATATTTTTATACTTAATGAATTGTATCTCATTAATCTCTTCCCTTACATCTTCATGTA 81 TTGTTGGTTTGTTTTTTGGTTTTGGGTTTTTTTTTTTTTTTTTTTGGTATAAGAACTAACATCAAAAGGCCTGTTTAAAG 161 GGAAAGGTTAATGGGCTACTTAATATTATGAACAAAACAAAAAAACAAGGCTGCCACAGTGGAATATTATCTTACAAGAA 241 TAAGAACTACATAAAACAGATTTGTAAAAAATACATATTTGAAGTATTCCCTGTATTTCCATTATTCTTTATGGAATATA 321 AAGTAAGCATGAAAGGTAGTTAAAACTTTCAGGTGCCTGTAGAGTCATAATAACTGTATTTTATGCCTTGCATTCACGCA 401 AATTCACATTGGATGTGATTTAAAAGTAGACATTCTCTTTTTCCTCTTTTAGGATATGTTTGATTACTGGAAAATTAATA 481 TGGTTATTTGTTAGAAGTCTGGTTTATAAAAAAGCCAAAAGTGATGGAATTTATTCCATTTGTCTTAGGAAGGCCCATAA 561 TACTTGTTTTTCTTACATGTGACTAGCAACTTTCTCCACTTAAAGACTAAATACCTCTTTATATGATGTAAATTATTCTA 641 ATTCATTTTAAAATCTTTTAGGTCAGCAAAATGTGTGTCTTCAGTGCTTTCTCTAAAAACGTTCCTTTATAGCTTTGTAC 721 TTTTTTTTTTAGCGTTGCCATTGAAAGTTAAAATGTTTGCATGGTTTACCCTCTGAGTTATGTTTCTTCTAGTGAGCATG 801 CCTGCTGTCACTAAGTGAATTATTTACTACTTTTTGTAGGTCTATATTTTAATAATTATTGGGATAATAATAATTGTGGT 881 ATGCTTTCCATTTACAAACCACTCATATACTTTAGTGTATGTCATCCTCAATAATCTAATGAGGTAAGTAGTATAAGTGT 961 TAGCTCTTTGCAGATAAGAAACTGAAACCCAGAAGTTTATTGAATTGCTTCATTGTTACCTAGCCAGCAAGGAGTGGAAT 1041 TAAAACTTGAACTCAGATCTTCTAATTTTCTGAGCTCATCCTTTCTCTTATACCTCAGATTGCAGACTAATCAAATTTTA 1121 CTTAAAACCTTCCTGATATTTTTGTTACCCTGGACACCCTTTCTATTCTAGAAAAGGTTTCCCATTTTATATGGAAGTGA 1201 CTAATTTTCAAGCTGCCAACAACTTATATCGAGGTAATATTTTATTCTCTGAATAAATTCATTTCACTTATATTAAAAGC 1281 ATAAGGAAATCTACATGTATGTAAAAATAACTTAGAAATTCAGTACATAATACATGATTGAATACATGATCGTATTTAAC 1361 ATGTTTTTTTTTTCTGCAGTGGACAAATAAACATCCTCAAAGTAGCAACTGCAAATCAGTTACCCTTAGAAAAGCAAGAC 1441 CAAACACTGTAGTTACACTATTAGCAGTGACCAAAAAGGGCTAATATTTTCTAAGAATAGTTTAAATTACAGACATTTGT 1521 TATATTTACCTTATGTGAAATACATCACTATTTAATTACATTAATTTTAACATCTGTTGTGTGGAGTTGTATAGTTCATG 1601 CAAAAGCCTGTGGGTATGGGTTTTTCAAACCAGCAGAAAGGTCAAAGGTACCTGAATGCTAAACTGCCTGGCTCCCAGCT 1681 TTTTCATTAAACTTTTCAGGGTCTTGGTTTCTTTATCTGTAAAATGACAGAGTTGGACCAGTTAACTTTAATGGCCATCC 1761 TTTTACACCACACAAGTTGATAAAATTTATCTGTTCAGCAAAGAGATTGAACAAAAAAGCACGTTAGTAATATGAAGACA 1841 GGAAAACGAATGAAAGTCTAACACATAACTCATATTGATTTACTTTATTTCTGTTAGATTTTACACTCTGAAAATTTCAC 1921 CTCATTTAGTTTGTACAAATACTAGACATGGAAACTTAAAATGTGCAGGTGTCAAAGCTTAAAAATCAGGTGTGTCCTCT 2001 TTAAAGGCATGTGCGATAAGCCTGCAGTCTTAACCAGACCTGGTACCAGTTTAACAGTTCATGATACTTCTGTGATGAGT 2081 GGATCTGTTAGTCTGGTAGAGATTAATGTTGAAATTTACTTGAATTACAGTTATTTGACAAGCCCACTTTTTTTGGAGTT 2161 TGGTGAGGAAGATAAGTAAAAATGCCCAACTAGTACAATGTGGAGAAAGTTTTCTGTTTGCTTGACTAAGGGAAATTGCT 2241 CAGAAAAAGAATGCTCCAACATGGGAATAAGGACCTTCAGTCTCAGGAACTCATTTTTGGGTGCAGTTTCTACATTTAAA 2321 AAATTGACTTGTGTTCAGTTTGATAACCAGTTCATTTGCTTTAGTCTCAGTGTTTTAAAGAAGTCTCATAATGTTCTACA 2401 AAGACACAAAGCTTCAGGCTTATACAAAACTGAGTATGATTAGAAATACCTGAGCCCAGAAATGATTCTGAGAAAAGAGA 2481 ATAATTTGAAGACACTTATTTAAAAGTAATTATGGTTAGAAATGAATTAATTTAAAAATGTGTTCACATATCCCTTTCTC 2561 TAACAGTTTAACCTAGACAAACATCTGTATCAGTATTTTTTTATTCCCCTGATTGATTACATTTGGTTTCTTTATTCTGA 2641 AAGGAAAATAACAAAAACTTCAGAAATTCCTAAGGGTGTAATAAGAAAGTGGGTTTTGAGTTTCCTTTCCTGGAATTATT 2721 TTACAGTTCTTTGGTGGGTCTCGTCAGCCAATTCATAGCTGGGCTTTAAGATTATCATCTTAGAGATGATAGATGGGCTT 2801 TTTAAAGATTTCATCTTAGAGATGAAAAGCTGGGCTTTTTCTCTAAGATGATAATCTTAAAGCCCAGCTATTAATTGATA 2881 ATGAACATTTTTCACTATTTTTTTTTCTATCTGAAGCTTAGAGATCTAGAGCTTTGGATCTTTCGGGTATATGTCAATGG 2961 AGGTATTATTTTATAATACTTTGCATTGACATGAAGTGGGTTCATGGGGGAAAACCATGAGCTGTGAACATTGGTAGCAA 3041 ACAAGCATATATTCATTTCAAAACTTTCCTTGCTTTTAGCAGAGAGAAGCCTGTATATGTTACATGTGTGACTTTCAGTA 3121 GTTTAAAGAGATGTTTCAAAAAATTGTTGCATGTTTTTGATGCAATTTGGGAAATTGTTTACTTCACAATGTAGTCATTC 3201 ATAAAAAAATTCATGAAAATACTGAACATATGTTTGAGGATTTTTCTTTTCCTTTTTAAATTTTTTTATTTTTTCTGAGA 3281 CGGAGATCTGCTCTTACGCCCAGGCTAGAGTGAAGTGGCGCGATCTTGGCTTACTGCAACCTCCACCCCCCAGGTTCAAG 3361 CGATTCTCCTGCCTCAGCCTCCGGAGTAGCTGGGATTACAGGCGCCCGCCACCACGTCCGGCTAATTTTTGTATTTTCAG 3441 TAGAGACGGGGTTTTGCTATGTTGGCCAGGCTGGTCTCAAACTCCTGACCTCAAGTGATCCACCTGCCTCGGCCTCCCAA 3521 AGTGTTAGGATAACAGGTGTGAGCCACCGTGCCCGGCTGAAGATTTTTCTTAATTGCAATAAATATTCAGCATTTTTTCT 3601 AATGAAAATGAATTTTGTTTACCAGTAAAAGTATGCATTTTAAAAGACTTTCAGATTTATGCTTTTTACGTGAAGCTGCT 3681 AAACTAAAAGTAAATGGAAGAAACCAAGTCTAGTAGGTTTTTTCTTTTTTTTTGTGGGGGTGGGATGGGGGAGGTTAGTT 3761 ACACTTAAAATATCTTCTCCAGAGACTGTATGCTCCTATACTAGACTGTAAGCTCTTTGAGGGCAGTCTGTCAGATTTAT 3841 CTTTGTATCTTCCCCAGCGCCTAGTGTAGTGCCTTGCACATAATAGGCGCCCAATAAATATTGATGAAGAATGAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 60559.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714645. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
CLIP-seq Support 1 for dataset GSM4903825 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / PID14_NS |
Location of target site | NM_021928 | 3UTR | AAACCACUCAUAUACUUUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161237 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903828 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / PID21_9124 |
Location of target site | NM_021928 | 3UTR | AAACCACUCAUAUACUUUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161237 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_021928 | 3UTR | UUUUUGUAGGUCUAUAUUUUAAUAAUUAUUGGGAUAAUAAUAAUUGUGGUAUGCUUUCCAUUUACAAACCACUCAUAUACUUUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_021928 | 3UTR | CUUUUUGUAGGUCUAUAUUUUAAUAAUUAUUGGGAUAAUAAUAAUUGUGGUAUGCUUUCCAUUUACAAACCACUCAUAUACUUUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM4903836 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_a |
Location of target site | NM_021928 | 3UTR | GGGAUAAUAAUAAUUGUGGUAUGCUUUCCAUUUACAAACCACUCAUAUACUUUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_021928 | 3UTR | CACUCAUAUACUUUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM714645 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repB |
Location of target site | ENST00000503362.1 | 3UTR | CUUUCCAUUUACAAACCACUCAUAUACUUUAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
85 hsa-miR-4745-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT100716 | TJAP1 | tight junction associated protein 1 | 2 | 2 | ||||||||
MIRT183592 | ZC3H11A | zinc finger CCCH-type containing 11A | 2 | 2 | ||||||||
MIRT338035 | DAZAP2 | DAZ associated protein 2 | 2 | 4 | ||||||||
MIRT395801 | SPCS3 | signal peptidase complex subunit 3 | 2 | 2 | ||||||||
MIRT443946 | LRIT3 | leucine rich repeat, Ig-like and transmembrane domains 3 | 2 | 2 | ||||||||
MIRT450579 | HIST1H2BG | histone cluster 1 H2B family member g | 2 | 6 | ||||||||
MIRT451616 | MEIS3P1 | Meis homeobox 3 pseudogene 1 | 2 | 2 | ||||||||
MIRT452330 | EIF5AL1 | eukaryotic translation initiation factor 5A-like 1 | 2 | 2 | ||||||||
MIRT453278 | EFTUD2 | elongation factor Tu GTP binding domain containing 2 | 2 | 2 | ||||||||
MIRT455213 | GNL1 | G protein nucleolar 1 (putative) | 2 | 2 | ||||||||
MIRT455469 | LYPLA2 | lysophospholipase II | 2 | 2 | ||||||||
MIRT456502 | PFKFB2 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 | 2 | 2 | ||||||||
MIRT456686 | LDB1 | LIM domain binding 1 | 2 | 2 | ||||||||
MIRT456914 | DDA1 | DET1 and DDB1 associated 1 | 2 | 2 | ||||||||
MIRT457602 | IDS | iduronate 2-sulfatase | 2 | 2 | ||||||||
MIRT457849 | RNASEH2B | ribonuclease H2 subunit B | 2 | 4 | ||||||||
MIRT458454 | RPRM | reprimo, TP53 dependent G2 arrest mediator homolog | 2 | 2 | ||||||||
MIRT460178 | UNK | unkempt family zinc finger | 2 | 6 | ||||||||
MIRT461464 | SLC19A3 | solute carrier family 19 member 3 | 2 | 2 | ||||||||
MIRT464738 | UBE2Q1 | ubiquitin conjugating enzyme E2 Q1 | 2 | 2 | ||||||||
MIRT465278 | TRIM28 | tripartite motif containing 28 | 2 | 2 | ||||||||
MIRT468449 | SETD1B | SET domain containing 1B | 2 | 2 | ||||||||
MIRT468619 | SUMO1 | small ubiquitin-like modifier 1 | 2 | 6 | ||||||||
MIRT469151 | RNF121 | ring finger protein 121 | 2 | 2 | ||||||||
MIRT470072 | PTGES2 | prostaglandin E synthase 2 | 2 | 2 | ||||||||
MIRT470171 | PSMD11 | proteasome 26S subunit, non-ATPase 11 | 2 | 4 | ||||||||
MIRT473155 | MLLT1 | MLLT1, super elongation complex subunit | 2 | 2 | ||||||||
MIRT474307 | LAMC1 | laminin subunit gamma 1 | 2 | 2 | ||||||||
MIRT474781 | KIAA0895L | KIAA0895 like | 2 | 2 | ||||||||
MIRT476482 | GATAD2A | GATA zinc finger domain containing 2A | 2 | 2 | ||||||||
MIRT477612 | EFNA3 | ephrin A3 | 2 | 2 | ||||||||
MIRT479523 | CDCA4 | cell division cycle associated 4 | 2 | 2 | ||||||||
MIRT479972 | CARD10 | caspase recruitment domain family member 10 | 2 | 2 | ||||||||
MIRT480409 | C19orf47 | chromosome 19 open reading frame 47 | 2 | 2 | ||||||||
MIRT480425 | C17orf85 | nuclear cap binding subunit 3 | 2 | 2 | ||||||||
MIRT483571 | SYT2 | synaptotagmin 2 | 2 | 2 | ||||||||
MIRT483663 | QSOX2 | quiescin sulfhydryl oxidase 2 | 2 | 4 | ||||||||
MIRT484531 | POLD3 | DNA polymerase delta 3, accessory subunit | 2 | 2 | ||||||||
MIRT484614 | SIX3 | SIX homeobox 3 | 2 | 6 | ||||||||
MIRT485896 | ZFP36 | ZFP36 ring finger protein | 2 | 2 | ||||||||
MIRT486504 | MYH11 | myosin heavy chain 11 | 2 | 2 | ||||||||
MIRT487506 | GRK5 | G protein-coupled receptor kinase 5 | 2 | 2 | ||||||||
MIRT488851 | UBTF | upstream binding transcription factor, RNA polymerase I | 2 | 2 | ||||||||
MIRT489463 | MSC | musculin | 2 | 2 | ||||||||
MIRT491168 | LRP3 | LDL receptor related protein 3 | 2 | 2 | ||||||||
MIRT496626 | TMEM67 | transmembrane protein 67 | 2 | 2 | ||||||||
MIRT497615 | ANG | angiogenin | 2 | 2 | ||||||||
MIRT497765 | KIAA0895 | KIAA0895 | 2 | 2 | ||||||||
MIRT499679 | MRE11A | MRE11 homolog, double strand break repair nuclease | 2 | 6 | ||||||||
MIRT499772 | SLC29A2 | solute carrier family 29 member 2 | 2 | 2 | ||||||||
MIRT501744 | NSD1 | nuclear receptor binding SET domain protein 1 | 2 | 2 | ||||||||
MIRT504993 | ZNF652 | zinc finger protein 652 | 2 | 2 | ||||||||
MIRT511663 | HIST1H3C | histone cluster 1 H3 family member c | 2 | 2 | ||||||||
MIRT511689 | HIST1H2BO | histone cluster 1 H2B family member o | 2 | 4 | ||||||||
MIRT511702 | HIST1H2BL | histone cluster 1 H2B family member l | 2 | 4 | ||||||||
MIRT511733 | HIST1H2BE | histone cluster 1 H2B family member e | 2 | 8 | ||||||||
MIRT512857 | TBC1D13 | TBC1 domain family member 13 | 2 | 2 | ||||||||
MIRT513443 | EMP1 | epithelial membrane protein 1 | 2 | 6 | ||||||||
MIRT515680 | TFPI | tissue factor pathway inhibitor | 2 | 2 | ||||||||
MIRT523528 | GLUL | glutamate-ammonia ligase | 2 | 2 | ||||||||
MIRT525545 | PHB2 | prohibitin 2 | 2 | 4 | ||||||||
MIRT526208 | SNX24 | sorting nexin 24 | 2 | 2 | ||||||||
MIRT531555 | SRD5A1 | steroid 5 alpha-reductase 1 | 2 | 2 | ||||||||
MIRT533763 | TMEM135 | transmembrane protein 135 | 2 | 2 | ||||||||
MIRT545581 | SNRPA1 | small nuclear ribonucleoprotein polypeptide A' | 2 | 2 | ||||||||
MIRT552433 | ZNF460 | zinc finger protein 460 | 2 | 2 | ||||||||
MIRT561158 | BCL2L12 | BCL2 like 12 | 2 | 2 | ||||||||
MIRT562344 | EXOSC2 | exosome component 2 | 2 | 2 | ||||||||
MIRT570658 | KDM6B | lysine demethylase 6B | 2 | 2 | ||||||||
MIRT571075 | TCHHL1 | trichohyalin like 1 | 2 | 2 | ||||||||
MIRT571331 | TPCN2 | two pore segment channel 2 | 2 | 2 | ||||||||
MIRT571601 | TOB2 | transducer of ERBB2, 2 | 2 | 2 | ||||||||
MIRT573012 | RPP25 | ribonuclease P and MRP subunit p25 | 2 | 2 | ||||||||
MIRT609042 | EP300 | E1A binding protein p300 | 2 | 2 | ||||||||
MIRT613397 | DNAH17 | dynein axonemal heavy chain 17 | 2 | 2 | ||||||||
MIRT635588 | TTC9C | tetratricopeptide repeat domain 9C | 2 | 2 | ||||||||
MIRT644753 | TXNRD3NB | thioredoxin reductase 3 neighbor | 2 | 2 | ||||||||
MIRT661117 | FPR1 | formyl peptide receptor 1 | 2 | 2 | ||||||||
MIRT690102 | PNMA2 | paraneoplastic Ma antigen 2 | 2 | 2 | ||||||||
MIRT694971 | PLAC8 | placenta specific 8 | 2 | 2 | ||||||||
MIRT695514 | ALPI | alkaline phosphatase, intestinal | 2 | 2 | ||||||||
MIRT695576 | ASB16 | ankyrin repeat and SOCS box containing 16 | 2 | 2 | ||||||||
MIRT699569 | SIT1 | signaling threshold regulating transmembrane adaptor 1 | 2 | 2 | ||||||||
MIRT701990 | MIER3 | MIER family member 3 | 2 | 2 | ||||||||
MIRT725462 | GRAP2 | GRB2-related adaptor protein 2 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|